Lakefront Biotherapeutics | GLPG - Валовая прибыль





Валовая прибыль Изменить Дата
argenx SE USD 1.18B 40.98M 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Biogen USD 2.12B 307M 2026-06
Genmab DKK 1.07B 240M 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
GRIFOLS EUR 704M 84M 2026-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Incyte USD 1.57B 400.89M 2026-06
Merck EUR 3.17B 101M 2026-06
Neurocrine Biosciences USD 800.7M 12.8M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
UCB EUR 3.19B 621M 2025-12
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06